Literature DB >> 9155857

Nebulisers for bronchiectasis.

D C Currie1.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9155857      PMCID： PMC1765864          DOI： 10.1136/thx.52.2008.s72

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  14 in total

1.  Evaluation of sodium colistimethate aerosol in gram-negative infections of the respiratory tract.

Authors:  H D Rose; M B Pendharker; G L Snider; R C Kory
Journal:  J Clin Pharmacol J New Drugs       Date:  1970 Jul-Aug

2.  Drug effects on mucociliary function.

Authors:  D Pavia; P P Sutton; M T Lopez-Vidriero; J E Agnew; S W Clarke
Journal:  Eur J Respir Dis Suppl       Date:  1983

3.  Nebulized colistin causes chest tightness in adults with cystic fibrosis.

Authors:  J Maddison; M Dodd; A K Webb
Journal:  Respir Med       Date:  1994-02       Impact factor: 3.415

4.  Pulmonary function tests and airway responsiveness to methacholine in chronic bronchiectasis of the adult.

Authors:  J Bahous; A Cartier; L Pineau; C Bernard; H Ghezzo; R R Martin; J L Malo
Journal:  Bull Eur Physiopathol Respir       Date:  1984 Jul-Aug

5.  Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy.

Authors:  P P Sutton; H G Gemmell; N Innes; J Davidson; F W Smith; J S Legge; J A Friend
Journal:  Thorax       Date:  1988-01       Impact factor: 9.139

6.  Controlled trial of natamycin in the treatment of allergic bronchopulmonary aspergillosis.

Authors:  D C Currie; C Lueck; H J Milburn; C Harvey; J L Longbottom; J H Darbyshire; A J Nunn; P J Cole
Journal:  Thorax       Date:  1990-06       Impact factor: 9.139

7.  Nebulized amoxicillin in chronic purulent bronchiectasis.

Authors:  R A Stockley; S L Hill; D Burnett
Journal:  Clin Ther       Date:  1985       Impact factor: 3.393

8.  Simple method of monitoring colonising microbial load in chronic bronchial sepsis: pilot comparison of reduction in colonising microbial load with antibiotics given intermittently and continuously.

Authors:  D C Currie; E Higgs; S Metcalfe; D E Roberts; P J Cole
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

9.  Atopy, immunological changes, and respiratory function in bronchiectasis.

Authors:  M B Murphy; D J Reen; M X Fitzgerald
Journal:  Thorax       Date:  1984-03       Impact factor: 9.139

10.  Present outlook in bronchiectasis: clinical and social study and review of factors influencing prognosis.

Authors:  D A Ellis; P E Thornley; A J Wightman; M Walker; J Chalmers; J W Crofton
Journal:  Thorax       Date:  1981-09       Impact factor: 9.139
View more
  1 in total

Review 1.  The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?

Authors:  D Banerjee; D Stableforth
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.